APO Research
Talk to an analyst

APO RESEARCH · REPORT

PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

30 December 2025194 pages

Choose your research edition.

Industry ResearchPIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine include Bioveta, Boehringer Ingelheim, CAVAC, Ceva Santé Animale, HIPRA, Jinyu Bio-Technology, Sinopharm Animal Health Co., Ltd, Zoetis and Harbin Pharmaceutical Group, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market size, projected growth trends, production technologies, key applications, and end-use industries.

PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Segment by Company

Bioveta

Boehringer Ingelheim

CAVAC

Ceva Santé Animale

HIPRA

Jinyu Bio-Technology

Sinopharm Animal Health Co., Ltd

Zoetis

Harbin Pharmaceutical Group

Merck

PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Segment by Type

CH-1R Strain

PC Strain

Others

PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Segment by Application

Gilts

Sows

PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Trends Table 2. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Drivers Table 3. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Opportunities and Challenges Table 4. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Restraints Table 5. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 7. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Manufacturers Table 9. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Manufacturers, Product Type & Application Table 13. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of CH-1R Strain Table 17. Major Manufacturers of PC Strain Table 18. Major Manufacturers of Others Table 19. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2021-2026) & (K Units) Table 21. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2027-2032) & (K Units) Table 22. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Type (2021-2026) Table 23. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Type (2027-2032) Table 24. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 25. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Type (2021-2026) & (K Units) Table 26. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Type (2027-2032) & (K Units) Table 27. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Type (2021-2026) Table 28. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Gilts Table 30. Major Manufacturers of Sows Table 31. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2021-2026) & (K Units) Table 33. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2027-2032) & (K Units) Table 34. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Application (2021-2026) Table 35. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Application (2027-2032) Table 36. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Application (2021-2026) & (K Units) Table 38. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Application (2027-2032) & (K Units) Table 39. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Application (2021-2026) Table 40. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Application (2027-2032) Table 41. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Region (2021-2026) & (K Units) Table 43. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Region (2021-2026) Table 44. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Forecasted Market Share by Region (2027-2032) Table 46. North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2021-2026) & (K Units) Table 48. North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2027-2032) & (K Units) Table 49. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2021-2026) & (K Units) Table 51. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2027-2032) & (K Units) Table 58. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 60. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 61. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Region (2021-2026) Table 62. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Region (2027-2032) Table 63. Bioveta Company Information Table 64. Bioveta Business Overview Table 65. Bioveta PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Bioveta PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 67. Bioveta Recent Development Table 68. Boehringer Ingelheim Company Information Table 69. Boehringer Ingelheim Business Overview Table 70. Boehringer Ingelheim PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Boehringer Ingelheim PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 72. Boehringer Ingelheim Recent Development Table 73. CAVAC Company Information Table 74. CAVAC Business Overview Table 75. CAVAC PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. CAVAC PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 77. CAVAC Recent Development Table 78. Ceva Santé Animale Company Information Table 79. Ceva Santé Animale Business Overview Table 80. Ceva Santé Animale PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Ceva Santé Animale PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 82. Ceva Santé Animale Recent Development Table 83. HIPRA Company Information Table 84. HIPRA Business Overview Table 85. HIPRA PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. HIPRA PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 87. HIPRA Recent Development Table 88. Jinyu Bio-Technology Company Information Table 89. Jinyu Bio-Technology Business Overview Table 90. Jinyu Bio-Technology PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Jinyu Bio-Technology PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 92. Jinyu Bio-Technology Recent Development Table 93. Sinopharm Animal Health Co., Ltd Company Information Table 94. Sinopharm Animal Health Co., Ltd Business Overview Table 95. Sinopharm Animal Health Co., Ltd PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Sinopharm Animal Health Co., Ltd PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 97. Sinopharm Animal Health Co., Ltd Recent Development Table 98. Zoetis Company Information Table 99. Zoetis Business Overview Table 100. Zoetis PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Zoetis PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 102. Zoetis Recent Development Table 103. Harbin Pharmaceutical Group Company Information Table 104. Harbin Pharmaceutical Group Business Overview Table 105. Harbin Pharmaceutical Group PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Harbin Pharmaceutical Group PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 107. Harbin Pharmaceutical Group Recent Development Table 108. Merck Company Information Table 109. Merck Business Overview Table 110. Merck PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Merck PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 112. Merck Recent Development Table 113. Key Raw Materials Table 114. Raw Materials Key Suppliers Table 115. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Distributors List Table 116. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Customers List Table 117. Research Programs/Design for This Report Table 118. Authors List of This Report Table 119. Secondary Sources Table 120. Primary Sources List of Figures Figure 1. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Image Figure 2. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (2021-2032) & (K Units) Figure 5. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. CH-1R Strain Image Figure 9. PC Strain Image Figure 10. Others Image Figure 11. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Type (2021-2032) Figure 14. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Type (2021-2032) Figure 17. Gilts Image Figure 18. Sows Image Figure 19. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Application (2021-2032) Figure 22. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Application (2021-2032) Figure 25. North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Country (2021-2032) Figure 27. U.S. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Country (2021-2032) Figure 32. Germany PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Country (2021-2032) Figure 39. China PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Country (2021-2032) Figure 47. Brazil PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue (2021-2032) & (US$ Million) Figure 58. North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue (2021-2032) & (US$ Million) Figure 60. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Value Chain Figure 66. Manufacturing Cost Structure Figure 67. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • CH-1R Strain
  • PC Strain
  • Others
Applications
  • Gilts
  • Sows
Companies covered
  • Bioveta
  • Boehringer Ingelheim
  • CAVAC
  • Ceva Santé Animale
  • HIPRA
  • Jinyu Bio-Technology
  • Sinopharm Animal Health Co., Ltd
  • Zoetis
  • Harbin Pharmaceutical Group
  • Merck

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Dynamics
  1. 2.1 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Trends
  2. 2.2 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Drivers
  3. 2.3 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Opportunities and Challenges
  4. 2.4 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Restraints
3 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market by Manufacturers
  1. 3.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Manufacturers (2021-2026)
  2. 3.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Manufacturers (2021-2026)
  3. 3.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Manufacturers, Product Type & Application
  7. 3.7 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Tier 1, Tier 2, and Tier 3
4 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market by Type
  1. 4.1 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Type Introduction
  2. 4.1.1 CH-1R Strain
  3. 4.1.2 PC Strain
  4. 4.1.3 Others
  5. 4.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type
  6. 4.2.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2021-2032)
  8. 4.2.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Type (2021-2032)
  9. 4.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Type
  10. 4.3.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Type (2021-2032)
  12. 4.3.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Type (2021-2032)
5 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market by Application
  1. 5.1 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Application Introduction
  2. 5.1.1 Gilts
  3. 5.1.2 Sows
  4. 5.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application
  5. 5.2.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2021-2032)
  7. 5.2.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Application (2021-2032)
  8. 5.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Application
  9. 5.3.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Application (2021-2032)
  11. 5.3.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Application (2021-2032)
6 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Region
  1. 6.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Region (2021-2032)
  3. 6.2.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Region (2021-2026)
  4. 6.2.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Region
  1. 7.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Region
  2. 7.1.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Region (2021-2026)
  4. 7.1.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Region (2027-2032)
  5. 7.1.4 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue (2021-2032)
  8. 7.2.2 North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue (2021-2032)
  11. 7.3.2 Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Bioveta
  2. 8.1.1 Bioveta Company Information
  3. 8.1.2 Bioveta Business Overview
  4. 8.1.3 Bioveta PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Bioveta PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  6. 8.1.5 Bioveta Recent Developments
  7. 8.2 Boehringer Ingelheim
  8. 8.2.1 Boehringer Ingelheim Company Information
  9. 8.2.2 Boehringer Ingelheim Business Overview
  10. 8.2.3 Boehringer Ingelheim PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Boehringer Ingelheim PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  12. 8.2.5 Boehringer Ingelheim Recent Developments
  13. 8.3 CAVAC
  14. 8.3.1 CAVAC Company Information
  15. 8.3.2 CAVAC Business Overview
  16. 8.3.3 CAVAC PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 CAVAC PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  18. 8.3.5 CAVAC Recent Developments
  19. 8.4 Ceva Santé Animale
  20. 8.4.1 Ceva Santé Animale Company Information
  21. 8.4.2 Ceva Santé Animale Business Overview
  22. 8.4.3 Ceva Santé Animale PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Ceva Santé Animale PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  24. 8.4.5 Ceva Santé Animale Recent Developments
  25. 8.5 HIPRA
  26. 8.5.1 HIPRA Company Information
  27. 8.5.2 HIPRA Business Overview
  28. 8.5.3 HIPRA PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 HIPRA PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  30. 8.5.5 HIPRA Recent Developments
  31. 8.6 Jinyu Bio-Technology
  32. 8.6.1 Jinyu Bio-Technology Company Information
  33. 8.6.2 Jinyu Bio-Technology Business Overview
  34. 8.6.3 Jinyu Bio-Technology PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Jinyu Bio-Technology PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  36. 8.6.5 Jinyu Bio-Technology Recent Developments
  37. 8.7 Sinopharm Animal Health Co., Ltd
  38. 8.7.1 Sinopharm Animal Health Co., Ltd Company Information
  39. 8.7.2 Sinopharm Animal Health Co., Ltd Business Overview
  40. 8.7.3 Sinopharm Animal Health Co., Ltd PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Sinopharm Animal Health Co., Ltd PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  42. 8.7.5 Sinopharm Animal Health Co., Ltd Recent Developments
  43. 8.8 Zoetis
  44. 8.8.1 Zoetis Company Information
  45. 8.8.2 Zoetis Business Overview
  46. 8.8.3 Zoetis PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Zoetis PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  48. 8.8.5 Zoetis Recent Developments
  49. 8.9 Harbin Pharmaceutical Group
  50. 8.9.1 Harbin Pharmaceutical Group Company Information
  51. 8.9.2 Harbin Pharmaceutical Group Business Overview
  52. 8.9.3 Harbin Pharmaceutical Group PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Harbin Pharmaceutical Group PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  54. 8.9.5 Harbin Pharmaceutical Group Recent Developments
  55. 8.10 Merck
  56. 8.10.1 Merck Company Information
  57. 8.10.2 Merck Business Overview
  58. 8.10.3 Merck PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Merck PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  60. 8.10.5 Merck Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Value Chain Analysis
  2. 9.1.1 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Production Mode & Process
  6. 9.2 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Distributors
  9. 9.2.3 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst